Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.

Balleari E, Filiberti RA, Salvetti C, Allione B, Angelucci E, Bruzzone M, Calzamiglia T, Cavaliere M, Cavalleri M, Cilloni D, Clavio M, Crisà E, Da Col A, Danise P, Pilo F, Ferrero D, Finelli C, Gioia D, Lemoli RM, Masiera E, Messa E, Miglino M, Musto P, Natalie Oliva E, Poloni A, Salvi F, Sanna A, Scudeletti M, Tassara R, Santini V.

Cancer Med. 2019 Oct 27. doi: 10.1002/cam4.2638. [Epub ahead of print]

2.

Characterization of Student Drinking Behaviors at the Beginning of the First Academic Year at One University in Southern Italy.

De Salvia MA, DʼUggento AM, Aquilino G, Tattoli M, Finelli C, Imbrici P, Desaphy JF, Giustino A.

J Addict Nurs. 2019 Jul/Sep;30(3):193-200. doi: 10.1097/JAN.0000000000000288.

PMID:
31478967
3.

Testing the relationship between microbiome composition and flux of carbon and nutrients in Caribbean coral reef sponges.

Gantt SE, McMurray SE, Stubler AD, Finelli CM, Pawlik JR, Erwin PM.

Microbiome. 2019 Aug 29;7(1):124. doi: 10.1186/s40168-019-0739-x.

4.

Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.

Falconi G, Fabiani E, Criscuolo M, Fianchi L, Finelli C, Cerqui E, Pelosi E, Screnci M, Gurnari C, Zangrilli I, Postorino M, Laurenti L, Piciocchi A, Testa U, Lo-Coco F, Voso MT.

Leuk Res. 2019 Sep;84:106191. doi: 10.1016/j.leukres.2019.106191. Epub 2019 Jul 19.

PMID:
31386932
5.

Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes.

Follo MY, Pellagatti A, Armstrong RN, Ratti S, Mongiorgi S, De Fanti S, Bochicchio MT, Russo D, Gobbi M, Miglino M, Parisi S, Martinelli G, Cavo M, Luiselli D, McCubrey JA, Suh PG, Manzoli L, Boultwood J, Finelli C, Cocco L.

Leukemia. 2019 Sep;33(9):2276-2290. doi: 10.1038/s41375-019-0416-x. Epub 2019 Feb 20.

6.

Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes.

Piciocchi A, Sargentini V, Cotugno F, Bontempi K, Beltrami G, Di Tucci AA, Riva M, Quaresmini G, Vallisa D, Finelli C, Borin L, Fazi P, Vignetti M, Angelucci E.

Eur J Haematol. 2019 May;102(5):442-443. doi: 10.1111/ejh.13222. Epub 2019 Mar 13. No abstract available.

PMID:
30776156
7.

Strategies to mitigate student resistance to active learning.

Tharayil S, Borrego M, Prince M, Nguyen KA, Shekhar P, Finelli CJ, Waters C.

Int J STEM Educ. 2018;5(1):7. doi: 10.1186/s40594-018-0102-y. Epub 2018 Mar 12.

8.

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).

Fabiani E, Calabrese C, Niscola P, Balleari E, Molteni A, Finelli C, Falconi G, Fenu S, Fianchi L, Criscuolo M, Salvi F, Lavorgna S, Buccisano F, Maurillo L, Lo Coco F, Cilloni D, Voso MT.

Br J Haematol. 2019 Jun;185(5):954-957. doi: 10.1111/bjh.15655. Epub 2018 Nov 8. No abstract available.

PMID:
30407614
9.

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.

Corradi G, Baldazzi C, Očadlíková D, Marconi G, Parisi S, Testoni N, Finelli C, Cavo M, Curti A, Ciciarello M.

Stem Cell Res Ther. 2018 Oct 25;9(1):271. doi: 10.1186/s13287-018-1013-z.

10.

Periwinkle climbing response to water- and airbone predator chemical cues may depend on home-marsh geography.

Carroll JM, Church MB, Finelli CM.

PeerJ. 2018 Oct 1;6:e5744. doi: 10.7717/peerj.5744. eCollection 2018.

11.

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.

Falconi G, Fabiani E, Piciocchi A, Criscuolo M, Fianchi L, Lindfors Rossi EL, Finelli C, Cerqui E, Ottone T, Molteni A, Parma M, Santarone S, Candoni A, Sica S, Leone G, Lo-Coco F, Voso MT.

Leukemia. 2019 Mar;33(3):785-790. doi: 10.1038/s41375-018-0284-9. Epub 2018 Oct 5. No abstract available.

12.

Corrigendum to "Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes".

Tarantino G, Finelli C, Scopacasa F, Pasanisi F, Contaldo F, Capone D, Savastano S.

Oxid Med Cell Longev. 2018 Aug 13;2018:6357164. doi: 10.1155/2018/6357164. eCollection 2018.

13.

Examination of the potential relationship between boring sponges and pea crabs and their effects on eastern oyster condition.

Watts JC, Carroll JM, Munroe DM, Finelli CM.

Dis Aquat Organ. 2018 Aug 28;130(1):25-36. doi: 10.3354/dao03257.

PMID:
30154269
14.

Corrigendum to "Sequence Analysis of the UCP1 Gene in a Severe Obese Population from Southern Italy".

Labruna G, Pasanisi F, Fortunato G, Nardelli C, Finelli C, Farinaro E, Contaldo F, Sacchetti L.

J Obes. 2018 Jul 19;2018:3260210. doi: 10.1155/2018/3260210. eCollection 2018.

15.

Alcohol use and abuse: a cross-sectional study among Italian adolescents.

Giustino A, Stefanizzi P, Ballini A, Renzetti D, De Salvia MA, Finelli C, Coscia MF, Tafuri S, De Vito D.

J Prev Med Hyg. 2018 Jun 1;59(2):E167-E171. eCollection 2018 Jun.

16.

Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.

Messa E, Gioia D, Masiera E, Castiglione A, Ceccarelli M, Salvi F, Danise P, Sanna A, Allione B, Balleari E, Poloni A, Cametti G, Ferrero D, Tassara R, Finelli C, Bonferroni M, Musto P, Saglio G, Levis A, Santini V.

Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3. No abstract available.

17.

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

Visani G, Loscocco F, Ruzzo A, Galimberti S, Graziano F, Voso MT, Giacomini E, Finelli C, Ciabatti E, Fabiani E, Barulli S, Volpe A, Magro D, Piccaluga P, Fuligni F, Vignetti M, Fazi P, Piciocchi A, Gabucci E, Rocchi M, Magnani M, Isidori A.

Pharmacogenomics J. 2018 May 22;18(3):444-449. doi: 10.1038/tpj.2017.48. Epub 2017 Dec 5.

PMID:
29205204
18.

Retraction: Nonalcoholic fatty liver disease, diet and gut microbiota.

Finelli C, Tarantino G.

EXCLI J. 2017 Oct 18;16:1164. eCollection 2017.

19.

Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.

Angelucci E, Cianciulli P, Finelli C, Mecucci C, Voso MT, Tura S.

Leuk Res. 2017 Nov;62:108-115. doi: 10.1016/j.leukres.2017.10.001. Epub 2017 Oct 5. Review.

PMID:
29054020
20.

Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs).

Poli A, Ratti S, Finelli C, Mongiorgi S, Clissa C, Lonetti A, Cappellini A, Catozzi A, Barraco M, Suh PG, Manzoli L, McCubrey JA, Cocco L, Follo MY.

FASEB J. 2018 Feb;32(2):681-692. doi: 10.1096/fj.201700690R. Epub 2018 Jan 4.

PMID:
28970249
21.

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.

Buckstein R, Balleari E, Wells R, Santini V, Sanna A, Salvetti C, Crisà E, Allione B, Danise P, Finelli C, Clavio M, Poloni A, Salvi F, Cilloni D, Oliva EN, Musto P, Houston B, Zhu N, Geddes M, Leitch H, Leber B, Sabloff M, Nevill TJ, Yee KW, Storring JM, Francis J, Maurillo L, Latagliata R, Spiriti MAA, Andriani A, Piccioni AL, Fianchi L, Fenu S, Gumenyuk S, Buccisano F.

Am J Hematol. 2017 Oct;92(10):1037-1046. doi: 10.1002/ajh.24842. Epub 2017 Jul 29.

22.

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

Santini V, Allione B, Zini G, Gioia D, Lunghi M, Poloni A, Cilloni D, Sanna A, Masiera E, Ceccarelli M, Abdel-Wahab O, Terenzi A, Angelucci E, Finelli C, Onida F, Pelizzari A, Ferrero D, Saglio G, Figueroa M, Levis A.

Leukemia. 2018 Feb;32(2):413-418. doi: 10.1038/leu.2017.186. Epub 2017 Jun 13.

23.

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.

Musto P, Maurillo L, Simeon V, Poloni A, Finelli C, Balleari E, Ricco A, Rivellini F, Cortelezzi A, Tarantini G, Villani O, Mansueto G, Milella MR, Scapicchio D, Marziano G, Breccia M, Niscola P, Sanna A, Clissa C, Voso MT, Fenu S, Venditti A, Santini V, Angelucci E, Levis A.

Br J Haematol. 2017 Jun;177(5):741-750. doi: 10.1111/bjh.14621. Epub 2017 Apr 17.

PMID:
28419408
24.

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Voso MT, Leone G, Piciocchi A, Fianchi L, Santarone S, Candoni A, Criscuolo M, Masciulli A, Cerqui E, Molteni A, Finelli C, Parma M, Poloni A, Carella AM, Spina F, Cortelezzi A, Salvi F, Alessandrino EP, Rambaldi A, Sica S.

Ann Oncol. 2017 Jul 1;28(7):1547-1553. doi: 10.1093/annonc/mdx154.

25.

WITHDRAWN: Dealing with visceral fat reduction to slow the progression of NAFLD.

Finelli C.

Surg Obes Relat Dis. 2016 Dec 27. pii: S1550-7289(16)30885-1. doi: 10.1016/j.soard.2016.12.021. [Epub ahead of print] No abstract available.

PMID:
28254261
26.

Retraction: The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss.

Finelli C, Crispino P, Gioia S, La Sala N, D'amico L, La Grotta M, Miro O, Colarusso D.

EXCLI J. 2016 Sep 19;15:570. eCollection 2016.

27.

Serum levels of Lp(a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities.

Tarantino G, Finelli C, Gioa S, Citro V, La Sala N, Gentile M.

Scand J Clin Lab Invest. 2016 Nov;76(7):544-552. Epub 2016 Jul 19.

PMID:
27433943
28.

The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss.

Finelli C, Crispino P, Gioia S, La Sala N, D'amico L, La Grotta M, Miro O, Colarusso D.

EXCLI J. 2016 Feb 23;15:166-76. doi: 10.17179/excli2015-642. eCollection 2016. Retraction in: EXCLI J. 2016 Sep 19;15:570.

29.

Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling.

Morello G, Imperatore R, Palomba L, Finelli C, Labruna G, Pasanisi F, Sacchetti L, Buono L, Piscitelli F, Orlando P, Di Marzo V, Cristino L.

Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4759-64. doi: 10.1073/pnas.1521304113. Epub 2016 Apr 11.

30.

Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes.

Finelli C, Follo MY, Stanzani M, Parisi S, Clissa C, Mongiorgi S, Barraco M, Cocco L.

Curr Pharm Des. 2016;22(16):2349-57.

PMID:
26960675
31.

Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes.

Mongiorgi S, Finelli C, Yang YR, Clissa C, McCubrey JA, Billi AM, Manzoli L, Suh PG, Cocco L, Follo MY.

Expert Opin Ther Targets. 2016 Jun;20(6):677-87. doi: 10.1517/14728222.2016.1125885. Epub 2015 Dec 17. Review.

PMID:
26610046
32.

Are oysters being bored to death? Influence of Cliona celata on Crassostrea virginica condition, growth and survival.

Carroll JM, O'Shaughnessy KA, Diedrich GA, Finelli CM.

Dis Aquat Organ. 2015 Nov 17;117(1):31-44. doi: 10.3354/dao02928.

33.

Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity?

Tarantino G, Citro V, Finelli C.

J Gastrointestin Liver Dis. 2015 Sep;24(3):359-68. doi: 10.15403/jgld.2014.1121.243.gta. Review.

34.

Treatment of two-part fractures of the surgical neck of the humerus using a locked metaphyseal intramedullary nail proximally with angular stability.

Viecili L, Turco DL, Ramalho JH, Finelli CA, Torini AP.

Rev Bras Ortop. 2015 Jan 23;50(1):22-9. doi: 10.1016/j.rboe.2015.01.001. eCollection 2015 Jan-Feb.

35.

Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population.

Savastano S, Tarantino G, D'Esposito V, Passaretti F, Cabaro S, Liotti A, Liguoro D, Perruolo G, Ariemma F, Finelli C, Beguinot F, Formisano P, Valentino R.

J Transl Med. 2015 May 29;13:169. doi: 10.1186/s12967-015-0532-y.

36.

Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease.

Tarantino G, Finelli C.

Future Microbiol. 2015;10(5):889-902. doi: 10.2217/fmb.15.13. Review.

PMID:
26000656
37.

An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes.

Cocco L, Finelli C, Mongiorgi S, Clissa C, Russo D, Bosi C, Quaranta M, Malagola M, Parisi S, Stanzani M, Ramazzotti G, Mariani GA, Billi AM, Manzoli L, Follo MY.

J Leukoc Biol. 2015 Nov;98(5):769-80. doi: 10.1189/jlb.2MA1114-541R. Epub 2015 May 14.

PMID:
25977289
38.

Poor outcome of acute respiratory infection in young children with underlying health condition in Brazil.

Durigon GS, Oliveira DB, Felicio MC, Finelli C, Pereira MF, Storni JG, Caldeira RN, Berezin RC, Durigon EL, Berezin EN.

Int J Infect Dis. 2015 May;34:3-7. doi: 10.1016/j.ijid.2015.03.003. Epub 2015 Mar 5.

39.

Interlocking screws placed with freehand technique and uni-planar image intensification: the "dip-stick" technique.

Finelli CA, Ziran BH, Torini AP, Fernandes HJ, Dos Reis FB.

Injury. 2014 Nov;45 Suppl 5:S21-5. doi: 10.1016/S0020-1383(14)70016-6.

PMID:
25528620
40.

Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Finelli C, Padula MC, Martelli G, Tarantino G.

World J Gastroenterol. 2014 Nov 28;20(44):16649-64. doi: 10.3748/wjg.v20.i44.16649. Review.

41.

Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.

Savastano S, Di Somma C, Colao A, Barrea L, Orio F, Finelli C, Pasanisi F, Contaldo F, Tarantino G.

Growth Horm IGF Res. 2015 Feb;25(1):28-33. doi: 10.1016/j.ghir.2014.10.006. Epub 2014 Oct 28.

PMID:
25466907
42.

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy.

Manzoli L, Mongiorgi S, Clissa C, Finelli C, Billi AM, Poli A, Quaranta M, Cocco L, Follo MY.

Mini Rev Med Chem. 2014 Oct 13. [Epub ahead of print]

PMID:
25307310
43.

Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease.

Tarantino G, Costantini S, Finelli C, Capone F, Guerriero E, La Sala N, Gioia S, Castello G.

PLoS One. 2014 Sep 30;9(9):e105610. doi: 10.1371/journal.pone.0105610. eCollection 2014.

44.

What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa?

Tarantino G, Citro V, Finelli C.

J Gastrointestin Liver Dis. 2014 Sep;23(3):291-9. doi: 10.15403/jgld.2014.1121.233.gvt.

45.

Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy.

Efficace F, Santini V, La Nasa G, Cottone F, Finelli C, Borin L, Quaresmini G, Di Tucci AA, Volpe A, Cilloni D, Quarta G, Sanpaolo G, Rivellini F, Salvi F, Molteni A, Voso MT, Alimena G, Fenu S, Mandelli F, Angelucci E.

BMJ Support Palliat Care. 2016 Mar;6(1):80-8. doi: 10.1136/bmjspcare-2014-000726. Epub 2014 Sep 9.

PMID:
25204541
46.

Alemtuzumab plus cyclosporine treatment of the autoimmune hemolytic anemia in an adult bowel transplant.

Lauro A, Stanzani M, Finelli C, Zanfi C, Morelli MC, Pasqualini E, Dazzi A, Ravaioli M, Di Simone M, Giudice V, Pironi L, Pinna AD.

Case Rep Transplant. 2014;2014:262953. doi: 10.1155/2014/262953. Epub 2014 Aug 11.

47.

Is serum Interleukin-17 associated with early atherosclerosis in obese patients?

Tarantino G, Costantini S, Finelli C, Capone F, Guerriero E, La Sala N, Gioia S, Castello G.

J Transl Med. 2014 Aug 6;12:214. doi: 10.1186/s12967-014-0214-1.

48.

Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes.

Tarantino G, Finelli C, Scopacasa F, Pasanisi F, Contaldo F, Capone D, Savastano S.

Oxid Med Cell Longev. 2014;2014:920676. doi: 10.1155/2014/920676. Epub 2014 Jun 17. Erratum in: Oxid Med Cell Longev. 2018 Aug 13;2018:6357164.

49.

Recreational drugs: a new health hazard for patients with concomitant chronic liver diseases.

Tarantino G, Citro V, Finelli C.

J Gastrointestin Liver Dis. 2014 Mar;23(1):79-84. Review.

50.

[The role of iron metabolism in myelodysplastic syndromes].

Finelli C, Clissa C, Stanzani M.

Recenti Prog Med. 2014 Mar;105(3):123-6. doi: 10.1701/1434.15874. Italian.

PMID:
24675455

Supplemental Content

Loading ...
Support Center